Latest filing published 07 Feb 2017 for ENDOCYTE INC, €2,186.
Insider track record
Michael A. Brinkley: trading record in brief
Michael A. Brinkley appears in our data through filings on Endocyte Inc shares, published by SEC (Form 4). Over a trading history stretching from 6 February 2014 to 6 February 2017, the count stands at 9 filings.
The filings describe grants, exercises and other transfers rather than trades on the open market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
On 7 February 2017 came the latest disclosure, a share grant for €2,186 in Endocyte Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Michael A. Brinkley
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,079 shares@ US$2.1865.2% of flowCommon StockSEC:0001179110-17-001935:0
- 578 shares@ US$2.1834.8% of flowCommon StockSEC:0001179110-17-001935:1
- 10,000 shares0Common StockSEC:0001179110-17-001597:0
- 5,000 sharesCommon StockSEC:0001144204-16-079687:0
- 618 sharesCommon StockSEC:0001144204-16-079687:1
- 580 sharesCommon StockSEC:0001144204-16-079687:2
- 5,000 shares0Common StockSEC:0001144204-15-006840:0
- 579 shares@ US$5.14Common StockSEC:0001144204-15-006840:1
- 6,250 shares0Common StockSEC:0001144204-14-007383:0
9 of 9 declarations